Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Modern obesity pharmacotherapies are not simply weight-loss agents
Roughly 24% of participants in the OASIS 4 trial of FDA-approved oral semaglutide did not lose 5% or more body weight
+ + .7 Important Medication Info: FDA-approved medications such as Saxenda, Victoza, Wegovy, and Ozempic are proprietary to Novo Nordisk, while Mounjaro and Zepbound are products of Eli Lilly and Company
55 mg Phosphatidylcholine (from soy lecithin)
BPC 157 500 mcg and PEA 500 mg x 60 Capsules $224.00Price
US$ 29.16
US$ 22.52
US$ 24.60
US$ 23.19
US$ 28.76
US$ 21.56
US$ 28.43
